Stock events for Viemed Healthcare, Inc. (VMD)
Over the past six months, Viemed Healthcare, Inc.'s stock has been impacted by several events, including the announcement of its Second and Third Quarter 2025 financial results. Viemed completed the acquisition of Lehan's Medical Equipment in July 2025 and a share repurchase program in September 2025. As of January 30, 2026, the share price was $7.67, reflecting a decline of 4.72% from February 3, 2025. Short interest in Viemed Healthcare increased by 10.08%, indicating a decrease in investor sentiment.
Demand Seasonality affecting Viemed Healthcare, Inc.’s stock price
There is an indication of demand seasonality for Viemed Healthcare's products and services, with the first quarter (Q1) traditionally being the weakest. Despite this, the company reported substantial improvements in net income and operating cash flow in Q1 2025 compared to the previous year.
Overview of Viemed Healthcare, Inc.’s business
Viemed Healthcare, Inc. specializes in home-based respiratory care solutions, operating within the Healthcare Providers and Services industry. The company offers post-acute respiratory services, respiratory disease management, in-home sleep testing, and sleep apnea treatment. Viemed supplies and leases home medical equipment like Non-Invasive Ventilators (NIVs), percussion vests, oxygen concentrators, and Positive Airway Pressure (PAP) machines, and also provides neuromuscular care and healthcare staffing services.
VMD’s Geographic footprint
Viemed Healthcare, Inc. is headquartered in Lafayette, Louisiana, and provides its services across the United States. As of 2020, it was approved to operate in 46 states and provide care for the Veterans Affairs (VA) Health System.
VMD Corporate Image Assessment
Viemed Healthcare is recognized as an expert in home-based respiratory care and disease management, committed to helping patients improve their breathing and live healthier lives. The company adheres to high standards of corporate governance, aiming to protect long-term shareholder value and ensure ethical operations. VMD exceeded the US Healthcare industry in shareholder returns over the past year. No specific negative events significantly impacting Viemed Healthcare's brand reputation in the past year were identified.
Ownership
Viemed Healthcare, Inc. has 252 institutional owners and shareholders holding a total of 28,737,834 shares. Major institutional owners include BlackRock, Inc., Forager Capital Management, LLC, and Vanguard Group Inc. Management also demonstrates shareholder alignment through high insider ownership.
Ask Our Expert AI Analyst
Price Chart
$8.70